Literature DB >> 7595059

A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes.

C S Engstad1, K Lia, O Rekdal, J O Olsen, B Osterud.   

Abstract

In a previous study we have shown that granulocytes enhance lipopolysaccharide (LPS)-induced tissue factor (TF) activity in monocytes in a platelet-dependent reaction. The present investigation was undertaken to examine the role of a platelet activation product, platelet factor 4 (PF4), in LPS-induced TF activity in monocytes. Platelet lysate supernatant, purified PF4, and the COOH-terminal tridecapeptide of PF4, termed PF4(58-70), enhanced LPS-induced TF activity in monocytes of whole blood dose dependently. A monoclonal antibody against P-selectin eliminated the enhancing effect of PF4(58-70) on LPS-induced TF activity in monocytes, and PF4(58-70) was shown to act synergistically with tumor necrosis factor alpha (TNF-alpha). However, PF4(58-70) did not enhance TNF-alpha secretion in LPS-stimulated whole blood. The major effect of PF4(58-70) was granulocyte dependent. Our results suggest that PF4 might play an important role in LPS-stimulated monocyte TF activity of whole blood.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595059     DOI: 10.1002/jlb.58.5.575

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

1.  Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection.

Authors:  Guanfang Shi; David J Field; Kyung-ae Ko; Sara Ture; Kalyan Srivastava; Scott Levy; M Anna Kowalska; Mortimer Poncz; Deborah J Fowell; Craig N Morrell
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

2.  Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR 4) domain: use of human-mouse chimaera and homologue-replacement mutagenesis.

Authors:  M H Ruchaud-Sparagano; E Malaud; O Gayet; E Chignier; R Buckland; J L McGregor
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

Review 3.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

Review 4.  Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease.

Authors:  Stavros Apostolakis; Georgios K Chalikias; Dimitrios N Tziakas; Stavros Konstantinides
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

5.  Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability.

Authors:  Elena M Egorina; Mikhail A Sovershaev; Geir Bjørkøy; Franz X E Gruber; Jan O Olsen; Behnaz Parhami-Seren; Kenneth G Mann; Bjarne Østerud
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-28       Impact factor: 8.311

6.  Platelet factor 4 inhibits IL-17/Stat3 pathway via upregulation of SOCS3 expression in melanoma.

Authors:  Shanshan Fang; Bo Liu; Qiushi Sun; Juan Zhao; Huixiong Qi; Quan Li
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

7.  Platelet factor 4 protects kidney allograft in a rat kidney transplantation model.

Authors:  Lei Zhang; Yichen Zhu; Dong Zhang; Jian Zhang; Ye Tian
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

8.  Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria.

Authors:  Kalyan Srivastava; David J Field; Angela Aggrey; Munekazu Yamakuchi; Craig N Morrell
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

9.  C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.

Authors:  A Landsem; E W Nielsen; H Fure; D Christiansen; J K Ludviksen; J D Lambris; B Østerud; T E Mollnes; O-L Brekke
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

10.  The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole blood.

Authors:  A Landsem; H Fure; D Christiansen; E W Nielsen; B Østerud; T E Mollnes; O L Brekke
Journal:  Clin Exp Immunol       Date:  2015-08-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.